InvestorsHub Logo
Followers 10
Posts 1104
Boards Moderated 0
Alias Born 12/07/2012

Re: sprot post# 26804

Monday, 05/08/2017 9:03:13 AM

Monday, May 08, 2017 9:03:13 AM

Post# of 38634
Gluco and Keppra are different. They said in their earnings they are exploring options. So there is your update, no deal yet, they're looking for ways to commercialize.

Focalin was different because they were told they had to redo the Bioequvilance data. A update on that could've been given I agree. But this isn't that scenario. For whatever reason the FDA jumped the gun and posted the "approvals" with out giving ipci their approval letters. If you want someone to tell you they haven't gotten an approval yet call and ask. I'm sure he will tell you they haven't been informed of an approval by the FDA.

We all know it should be coming any day now. It's been 5 business days. If it doesn't come in the near future and they receive some communication from the FDA as per a reason WHY, then maybe there is cause to issue a PR and inform shareholders. But as of now its business as usual until the FDA advises them of anything good or bad.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News